Treefrog Therapeutics
- Home
- Companies
- Treefrog Therapeutics
- Articles
- Interview: Teisha Rowland, Ph.D., ...
Interview: Teisha Rowland, Ph.D., Principal Scientist, Umoja Biopharma
Jul. 3, 2022
Courtesy ofTreefrog Therapeutics
We had the chance to interview Teisha Rowland, Ph.D., Principal Scientist at Umoja Biopharma during the ISSCR in San Francisco about the Umoja/TreeFrog partnership. Leading iPSC engineering at Umoja, she comes back on the vision of Umoja, its RACR™ technology and her interest in TreeFrog’s C-Stem™ platform for the development of iPSC-derived allogeneic products in immuno-oncology.
Most popular related searches